SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-18-000115
Filing Date
2018-02-12
Accepted
2018-02-12 13:17:03
Documents
2
Group Members
ANDREW H. WARFORDLEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss79101_13g.htm SC 13G 114412
2 JOINT FILING AGREEMENT ss79101_ex99a.htm EX-99.A 17609
  Complete submission text file 0000947871-18-000115.txt   133681
Mailing Address 300 CRESCENT COURT 18TH FLOOR DALLAS TX 75201
Business Address 300 CRESCENT COURT 18TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX
Type: SC 13G

Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48867 | Film No.: 18595398
SIC: 2834 Pharmaceutical Preparations